Renalytix Plc (LON:RENX) Insider Christopher H. B. Mills Sells 83,696 Shares of Stock

Renalytix Plc (LON:RENXGet Free Report) insider Christopher H. B. Mills sold 83,696 shares of the company’s stock in a transaction that occurred on Monday, October 7th. The shares were sold at an average price of GBX 8 ($0.10), for a total value of £6,695.68 ($8,762.83).

Renalytix Stock Performance

Shares of RENX stock opened at GBX 7.50 ($0.10) on Friday. The company has a debt-to-equity ratio of 173.95, a current ratio of 0.53 and a quick ratio of 2.42. The stock’s 50 day simple moving average is GBX 10.79 and its two-hundred day simple moving average is GBX 17.35. Renalytix Plc has a 1 year low of GBX 7 ($0.09) and a 1 year high of GBX 74.90 ($0.98). The company has a market cap of £12.44 million, a PE ratio of -32.38 and a beta of 2.10.

About Renalytix

(Get Free Report)

Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record systems to generate a unique patient risk score.

Further Reading

Receive News & Ratings for Renalytix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Renalytix and related companies with MarketBeat.com's FREE daily email newsletter.